Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

MyStart Health vs OnlyRx

MyStart Health
Graded #168

Higher grade

vs+6.199999999999996
OnlyRx
Graded #309

Lower grade

The verdict

MyStart Health takes it — 67.1/100 to 60.9/100.

MyStart Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. MyStart Health offers all-inclusive compounded semaglutide and tirzepatide at $299/month with a price-lock guarantee, same-day physician consultations, and 24/7 care team access.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMyStart Health +6
48
42
Dose & formulationOnlyRx +5
83
88
Clinical oversightMyStart Health +12
84
72
Labs & monitoringMyStart Health +14
66
52
FulfillmentMyStart Health +26
78
52
Contract termsOnlyRx +24
31
55
MyStart Health · left barOnlyRx · right bar

The numbers

MetricMyStart HealthOnlyRx
WeighScore67.1/10060.9/100
GradeCC
Scorecard rank#168#309
Semaglutide$299/mo (all doses, compounded)$179/mo (starting dose, promotional rate, compounded)
Tirzepatide$299/mo (all doses, compounded)$249/mo (starting dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualYesYes
MyStart Health

Graded #168 · C

Strengths

  • Price Lock Guarantee — your $299 base rate doesn't rise as your dose escalates
  • Fast onboarding: roughly 5-minute intake, 24-hour prescription turnaround, 2–4 day shipping
  • 24/7 care team access with unlimited clinician messaging included
  • LegitScript certified
  • Clear Section 503A compounding disclosure on every landing page

Where it loses points

  • Not BBB accredited — C+ rating with 10 complaints, mostly shipping delays and support access
  • Compounded only — no FDA-approved Ozempic, Wegovy, Zepbound, or Mounjaro
  • Markets oral tirzepatide, but no FDA-approved oral tirzepatide exists
  • Very new company (incorporated May 2024) with a limited track record
  • Pharmacy partners not named, so 503A compliance can't be independently verified
OnlyRx

Graded #309 · C

Strengths

  • Four-pharmacy network: Belmar, Strive, Epiq Scripts, and Casa Pharma RX
  • Named prescribers on the public site: Dr. Carr (MD), Dr. Tenbrink (MD), Dr. Italia (MD), Dr. Mansour (DO)
  • Oral disintegrating tablet (ODT) form for both semaglutide and tirzepatide — good for needle-averse patients
  • Pricing, drug list, pharmacy partners, and physician roster all visible on the public site
  • LegitScript Certified

Where it loses points

  • Promo pricing ($179 semaglutide injection) is prominent, but post-promo maintenance pricing isn't shown
  • No titration-ladder pricing — you can't see costs at 1.0 mg or 2.4 mg maintenance
  • Refund / cancellation policy not stated on the homepage
  • Lab-work requirement not stated
  • Operating corporate entity not disclosed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard